Antiva Biosciences

Stopping Cancer Before It Starts

South San Francisco, United States · Founded 2012 · $121.0M raised

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$121.0M
Last Round
$53.0M Series EApr 2023
Rounds
4

About

Antiva Biosciences is a clinical-stage biopharmaceutical company developing novel topical therapeutics for the treatment of oncogenic HPV infections and pre-cancerous cervical lesions. Their lead therapy aims to give women a non-surgical, at-home treatment option — the first approved drug treatment for HPV infection — supporting the WHO's global Cervical Cancer Elimination Initiative.

Summary

Antiva Biosciences is a Biotech company based in South San Francisco, United States, founded in 2012. It has raised $121.0M in total across 4 rounds, most recently a $53.0M Series E round in Apr 2023. Investors include MPM BioImpact, HBM Partners and Sirona Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ESeries EApr 2023
$53.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Antiva Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/antiva-biosciences"><img src="https://indexed.vc/api/badge/company/antiva-biosciences" alt="Antiva Biosciences on Indexed.vc" width="260" height="76" /></a>